By Dr James Phuc Huu Pham

Book Chapters

Pham JP; Frew JW, 2023, 'Management of Immunosuppressed Dermatology Patients During COVID-19', in Updates in Clinical Dermatology, Springer Nature Switzerland, pp. 109 - 120, http://dx.doi.org/10.1007/978-3-031-45586-5_11

Journal articles

Aghajani M; Pham J; Sholji T; Burrell K; Kok C; Frew JW, 2026, 'Originator versus biosimilar adalimumab in hidradenitis suppurativa: A multicenter real-world analysis of clinical response, maintenance of response, and switching', Jaad International, 24, pp. 9 - 15, http://dx.doi.org/10.1016/j.jdin.2025.05.023

Mangkorntongsakul V; Joseph JS; Pham JP; Smith SD; Chow CK; Smith AD, 2025, 'Biologic Therapies and Major Cardiovascular Events in Psoriasis: Updated Systematic Review and Meta-analysis', Dermatology and Therapy, 15, pp. 3547 - 3560, http://dx.doi.org/10.1007/s13555-025-01529-5

Pham J; Sholji T; Islam R; Burrell K; Kok C; Frew JW, 2025, 'Sequencing of Biologic Therapy in Hidradenitis Suppurativa: A Real-World Analysis of Treatment in Over 15,000 Patients', JEADV Clinical Practice, 4, pp. 1127 - 1129, http://dx.doi.org/10.1002/jvc2.70083

Li GX; Sun HY; Pham JP; Tatian AH; Polcz M; Chee SN; Shih STF; Sebaratnam DF, 2025, 'Cost-utility analysis of upadacitinib vs. dupilumab for atopic dermatitis in Australia', Clinical and Experimental Dermatology, 50, pp. 1551 - 1560, http://dx.doi.org/10.1093/ced/llaf097

Sholji T; Islam R; Pham J; Burrell K; Kok C; Frew JW, 2025, 'Quantifying time to medical and/or surgical therapy after diagnosis of hidradenitis suppurativa and pilonidal sinus disease: A propensity-matched real-world cohort analysis', Journal of the European Academy of Dermatology and Venereology, 39, pp. e671 - e672, http://dx.doi.org/10.1111/jdv.20494

Barbieri JS; Rubin CB; Pham JP; Wong M, 2025, 'The Need for Transparency and Careful Messaging Regarding the Potential for Benzoyl Peroxide Products to Form Benzene', Journal of Investigative Dermatology, 145, pp. 2074 - 2076.e1, http://dx.doi.org/10.1016/j.jid.2025.01.027

Li GX; Chen K; Sebaratnam DF; Pham JP, 2025, 'Ichthyosis Prematurity Syndrome: A Systematic Review of the Literature', Pediatric Dermatology, 42, pp. 747 - 753, http://dx.doi.org/10.1111/pde.15909

Staeger R; Tastanova A; Ghosh A; Winkelbeiner N; Shukla P; Kolm I; Turko P; Benlahrech A; Harper J; Broomfield A; Camera A; Ambrosio M; Haunerdinger V; Cheng PF; Ramelyte E; Pham J; Kreutmair S; Becher B; Levesque MP; Dummer R; Meier-Schiesser B, 2025, 'Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients', Journal of Clinical Investigation, 135, http://dx.doi.org/10.1172/JCI181464

Sholji T; Islam R; Pham J; Kok C; Frew JW, 2025, 'Malignancy risk differs between hidradenitis suppurativa and pilonidal sinus disease', Journal of the American Academy of Dermatology, 92, pp. 1381 - 1382, http://dx.doi.org/10.1016/j.jaad.2025.01.076

Flora A; Pham J; Woods JA; Radzeika M; Dickson H; Malone M; Frew JW, 2025, 'The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical Trial', Journal of Investigative Dermatology, 145, pp. 1396 - 1406.e6, http://dx.doi.org/10.1016/j.jid.2024.10.602

Li GX; Sebaratnam DF; Pham JP, 2025, 'Targeted Therapies for Slow-Flow Vascular Malformations', Australasian Journal of Dermatology, 66, pp. 142 - 151, http://dx.doi.org/10.1111/ajd.14451

Barbieri JS; Rubin CB; Pham JP; Wong M, 2025, 'The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products', JAMA Dermatology, 161, pp. 442 - 444, http://dx.doi.org/10.1001/jamadermatol.2024.6443

Pham J; Frew JW, 2025, 'Hidradenitis Suppurativa: Pathogenesis and Inflammatory Pathways', Dermatologic Clinics, 43, pp. 179 - 191, http://dx.doi.org/10.1016/j.det.2024.12.004

Li GX; Chen K; Sebaratnam DF; Pham JP, 2025, 'Ichthyosis Prematurity Syndrome', Australasian Journal of Dermatology, 66, pp. 107 - 109, http://dx.doi.org/10.1111/ajd.14419

Sebaratnam DF; Pham JP, 2025, 'Tumoral Melanosis', New England Journal of Medicine, 392, pp. 698, http://dx.doi.org/10.1056/NEJMicm2413467

Pham JP; Mangkorntongsakul V; Gorji M; Nguyen D; Lochhead A; Kim J; Smith A, 2025, 'Acute generalized exanthematous pustulosis and generalized pustular psoriasis: not so different differentials?', International Journal of Dermatology, 64, pp. 419 - 421, http://dx.doi.org/10.1111/ijd.17388

Pham JP; Staeger R; Joshua AM; Liu J; da Silva IP; Dummer R; Goldinger SM, 2025, 'An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanoma', European Journal of Cancer, 214, http://dx.doi.org/10.1016/j.ejca.2024.115121

Pham J; Flora A; Kozera EK; Medianfar CE; Bouazzi D; Christensen R; Jemec GBE; Frew JW, 2025, 'Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, Australia', Dermatology, http://dx.doi.org/10.1159/000540455

Pham JP; Kondo M; Hurwitz J; Cosman R; Goldinger SM; Dummer R; Sim HW; Joshua AM, 2025, 'Efficacy of immune checkpoint inhibitors in advanced mucosal melanoma: A systematic review and meta-analysis', Ejc Skin Cancer, 3, http://dx.doi.org/10.1016/j.ejcskn.2025.100756

Frew J; Flora A; Pham J; Woods J; Radzieta M; Dickson H; Malone M, 2025, '61257 The Clinical and Molecular Response of Pyoderma Gangrenosum to Interleukin 23 Blockade: Result from a proof-of-concept open-label clinical trial', Journal of the American Academy of Dermatology, 93, pp. AB313 - AB313, http://dx.doi.org/10.1016/j.jaad.2025.05.1236

Frew J; Pham J; Sholji T; Guttman L; Allen T, 2025, '61380 Predictors of wound healing after surgical deroofing in Hidradenitis Suppurativa', Journal of the American Academy of Dermatology, 93, pp. AB72 - AB72, http://dx.doi.org/10.1016/j.jaad.2025.05.292

Frdew J; Pham J; Sholji T, 2025, '61381 Gender Influences Clinical Response to Guselkumab in Hidradenitis Suppurativa: A post-hoc analysis of Phase 2 Individual Patient Data', Journal of the American Academy of Dermatology, 93, pp. AB49 - AB49, http://dx.doi.org/10.1016/j.jaad.2025.05.199

Shekar S; Hall A; Pham J; Crumbaker M; Liu J; Talmor B; Sim HW; Joshua AM, 2025, 'Efficacy of systemic therapy in metastatic adrenocortical carcinoma: a meta-analysis of prospective clinical trials.', Endocr Oncol, 5, pp. e250027, http://dx.doi.org/10.1530/EO-25-0027

Pham JP; Sebaratnam DF, 2024, 'Cost-utility and actionability of genomic sequencing for inflammatory linear verrucous epidermal nevus', Journal of the American Academy of Dermatology, 91, pp. e163 - e164, http://dx.doi.org/10.1016/j.jaad.2024.06.080

Pham J; Sholji T; Guttman L; Allan T; Frew JW, 2024, 'Predictors of wound healing after surgical deroofing in Hidradenitis Suppurativa', Australasian Journal of Dermatology, 65, pp. 636 - 641, http://dx.doi.org/10.1111/ajd.14375

Pham J; Flora A; Guttman L; Allan T; Chandran NS; Frew JW, 2024, 'Response to adalimumab in Caucasian and Asian patients with hidradenitis suppurativa: A retrospective cohort study of an Australian cohort stratified by patient-reported ethnicity', Australasian Journal of Dermatology, 65, pp. 560 - 566, http://dx.doi.org/10.1111/ajd.14343

Pham JP; Allen N; Star P; Cust A; Guitera P; Marghoob AA; Paoli J; Zalaudek I; Smith A, 2024, 'Full-body skin examination in screening for cutaneous malignancy: A focus on concealed sites and the practices of international dermatologists', JEADV Clinical Practice, 3, pp. 1132 - 1139, http://dx.doi.org/10.1002/jvc2.437

Pham JP; Rosenø NAL; Roccuzzo G; Saal RC; Egeberg A; Ring HC; Frew JW, 2024, 'Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis', Journal of the American Academy of Dermatology, 91, pp. 170 - 172, http://dx.doi.org/10.1016/j.jaad.2024.03.028

Pham JP; Zdanska O; Selga M; Javier J; O'Grady A; Chin V; Forstner D; Hsu E; Liu J, 2024, 'Onkolytische Viren zur Verstärkung der PD-1-Hemmung bei metastasierendem kutanem Plattenepithelkarzinom', JDDG Journal of the German Society of Dermatology, 22, pp. 1016 - 1019, http://dx.doi.org/10.1111/ddg.15423_g

Gu Y; Pham JP; Sebaratnam DF, 2024, 'Towards precision medicine in vascular anomalies: Could protein kinase C inhibitors be repurposed for GNAQ/11-related phakomatoses?', Skin Research and Technology, 30, http://dx.doi.org/10.1111/srt.13736

Pham JP; Staeger R; Frew JW, 2024, 'More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence', Journal of the American Academy of Dermatology, 90, pp. e171 - e173, http://dx.doi.org/10.1016/j.jaad.2023.11.064

Pham JP; Flora A; Frew JW, 2024, 'Understanding multi-kinase inhibitor-associated cutaneous ulcers may provide molecular insights into the aetiology of pyoderma gangrenosum: A comment on Jeon et al.', Australasian Journal of Dermatology, 65, pp. e81 - e84, http://dx.doi.org/10.1111/ajd.14221

Flora A; Jepsen R; Pham J; Frew JW, 2024, 'Alterations to the Hidradenitis Suppurativa Serum Proteome with Spleen Tyrosine Kinase Antagonism: Proteomic Results from a Phase 2 Clinical Trial', Journal of Investigative Dermatology, 144, pp. 786 - 793.e1, http://dx.doi.org/10.1016/j.jid.2023.10.005

Pham JP; Jepsen R; Frew JW, 2024, 'Comment on Kridin et al.—Considering both relative and absolute risk differences in infection risk between biologics classes in patients with psoriasis', Journal of the European Academy of Dermatology and Venereology, 38, pp. e351 - e353, http://dx.doi.org/10.1111/jdv.19615

Pham JP; Allen N; Star P; Cust AE; Stewart C; Guitera P; Marghoob AA; Smith A, 2024, 'Full-body skin examination in screening for cutaneous malignancy: a focus on concealed sites and the practices of Australian dermatologists', International Journal of Dermatology, 63, pp. 467 - 473, http://dx.doi.org/10.1111/ijd.16942

Flora A; Pham J; Jepsen R; Frew JW, 2024, 'The serum proteome of pyoderma gangrenosum is more expansive than that of hidradenitis suppurativa', Journal of the European Academy of Dermatology and Venereology, 38, pp. e348 - e350, http://dx.doi.org/10.1111/jdv.19611

Flora A; Jepsen R; Pham J; Frew JW, 2024, 'Rapid Attenuation of B-Cell and IFN-γ–Associated Chemokines in Clinical Responders to Jak Inhibition with Upadacitinib in Hidradenitis Suppurativa', Journal of Investigative Dermatology, 144, pp. 416 - 419.e5, http://dx.doi.org/10.1016/j.jid.2023.07.023

Pham JP; Rodrigues A; Goldinger SM; Sim H-W; Liu JJ, 2024, 'Epidermal growth factor receptor inhibitors in advanced cutaneous squamous cell carcinoma: A systematic review and meta-analysis', Experimental Dermatology, 33, http://dx.doi.org/10.1111/exd.14978

Pham JP; Zdanska O; Selga M; Javier J; O'Grady A; Chin V; Forstner D; Hsu E; Liu J, 2024, 'Oncolytic viruses to augment PD-1 inhibition in metastatic cutaneous squamous cell carcinoma', JDDG - Journal of the German Society of Dermatology, 22, pp. 1016 - 1018, http://dx.doi.org/10.1111/ddg.15423

Zhang L; Ng K; Pham JP; Thoo S; Yang A; Kang M; Connor D; Kossard S; Parsi K, 2023, 'Pigmentation of lower limbs: Contribution of haemosiderin and melanin in chronic venous insufficiency and related disorders', Phlebology, 38, pp. 657 - 667, http://dx.doi.org/10.1177/02683555231196702

Pham JP; Wark KJL; Woods J; Frew JW, 2023, 'Resident cutaneous memory T cells: a clinical review of their role in chronic inflammatory dermatoses and potential as therapeutic targets', British Journal of Dermatology, 189, pp. 656 - 663, http://dx.doi.org/10.1093/bjd/ljad303

Pham JP; Dwyer L; Phan K; Menzies AM; Frew JW, 2023, 'Efficacy of topical diphencyprone for melanoma in-transit metastases: a systematic review and meta-analysis', Melanoma Research, 33, pp. 434 - 436, http://dx.doi.org/10.1097/CMR.0000000000000914

Pham JP; Frew JW, 2023, 'Reply to Tilotta and Bongiorno: Considering the role of resident cutaneous memory T-cell suppression in providing durable atopic dermatitis remission', Journal of the European Academy of Dermatology and Venereology, 37, pp. e1173 - e1174, http://dx.doi.org/10.1111/jdv.19179

Pham JP; On L; Ardolino L; Hurwitz J; Salaun H; Sim HW; Joshua AM, 2023, 'Efficacy of immune checkpoint inhibition in metastatic uveal melanoma: a systematic review and meta-analysis', Melanoma Research, 33, pp. 316 - 325, http://dx.doi.org/10.1097/CMR.0000000000000900

Pham JP; Joshua AM; da Silva IP; Dummer R; Goldinger SM, 2023, 'Chemotherapy in Cutaneous Melanoma: Is There Still a Role?', Current Oncology Reports, 25, pp. 609 - 621, http://dx.doi.org/10.1007/s11912-023-01385-6

Pham JP; Boot M; Stefani M; Chapman S; Byrne A; Abdel-Shaheed C; Girgis L, 2023, 'Disseminated Mycobacterium chelonae infection complicating rheumatoid arthritis: A case report and review of the literature', International Journal of Rheumatic Diseases, 26, pp. 1167 - 1171, http://dx.doi.org/10.1111/1756-185X.14605

Pham JP; Yang A; Frew JW, 2023, 'Academic dermatology in Australia and New Zealand between 2017 and 2022: A cross-sectional bibliometric analysis', Australasian Journal of Dermatology, 64, pp. 213 - 220, http://dx.doi.org/10.1111/ajd.14025

Pham JP; Hillman RJ; Smith A, 2023, 'Re: ‘The impact of systemic psoriasis treatments on human papillomavirus activation and propagation’—What about anal malignancies?', Australasian Journal of Dermatology, 64, pp. e204 - e206, http://dx.doi.org/10.1111/ajd.14009

Pham JP; Sivasubramaniam V; Gallagher R; Forstner D; Wong M; Liu J, 2023, 'Safety of cemiplimab for advanced cutaneous squamous cell carcinoma in a patient with p-ANCA-associated vasculitis', Journal of the European Academy of Dermatology and Venereology, 37, pp. e363 - e365, http://dx.doi.org/10.1111/jdv.18649

Back to profile page